David P. Perry
Co-Founder & Executive ChairmanMr. David P. Perry, M.B.A., is a Co-Founder and Executive Chairman at Better Therapeutics, Inc and has been its Director since October 2021. Mr. Perry served as the President of Indigo Agriculture, Inc. until September 2020. Mr. Perry had been the Chief Executive Officer and Director of Indigo (alternate names, Symbiota, Inc. and Indigo Symbiota, Inc.) since January 7, 2015 until September 2020. He served as President & Chief Executive Officer at Indigo Ag, Inc. since January 07, 2015 and served as its Chief Executive Officer. He was a co-Founder of Anacor Pharmaceuticals. Mr. Perry served as the Chief Executive Officer and President at Anacor Pharmaceuticals, Inc. from March 2002 to March 19, 2014. He served as the Chief Executive Officer of Chemdex. Mr. Perry co-founded NexPrise, Inc. in September 1997 and also served as its Chief Executive Officer and President until November 2001. He co-founded Virogen Inc., a biotechnology company and served in various positions from December 1995 to April 1997, including its Chief Executive Officer and President. He also held various positions at Exxon Corporation, including Refinery Operations Supervisor from January 1994 to May 1995, Financial Analyst from March 1993 to January 1994, Project Manager from September 1992 to March 1993 and Engineer from September 1990 to March 1992. He served as Vice Chairman of the Board of Directors at Nexprise, Inc. since November 2001 and served as its Director since September 1997. He has been a Director of Evelo Therapeutics, Inc. since July 12, 2016. Mr. Perry had been Independent Director at Evelo Biosciences, Inc. since June 2016 until June 09, 2022. He serves as a Director of Infectious Disease Research Institute and A. P. Giannini Foundation. Mr. Perry served as a Director of Anacor Pharmaceuticals, Inc., a privately-held company in the bio-technology industry since March 2002 to March 2014. He served as a Director of 3Plex.com, Inc. He also attended the United States Air Force Academy from 1986 to 1988, where he was a National Merit Scholar. Mr. Perry holds an M.B.A. from Harvard Business School in 1995-1997 and a B.S. in Chemical Engineering from the University of Tulsa in 1988-1990.
Positions
- Company NameBetter Therapeutics, Inc.Stock CodeBTTXPositionCo-Founder & Executive ChairmanColleagues
- FLFrank L. KarbeInterim CFO
- MAMark A. BermanChief Medical Officer
- KWKristin WynholdsChief Product Officer
- ACAndres CamachoSenior VP of Technology & Head of Engineering
- AJAndrew J. ArmaninoIndependent Director
- GMGeoffrey M. ParkerIndependent Director
- RHRichard H. CarmonaIndependent Director
- EGElder GrangerIndependent Director
